...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Waiting for some great news about Zenith

Maybe starting in Q4, 2022

Share
New Message
Please login to post a reply